戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nts with stable CAD taking low-dose aspirin (acetylsalicylic acid).
2 stoperative low-dose intravenous heparin and acetylsalicylic acid.
3 spirin was associated with lower exposure to acetylsalicylic acid (63% and 70% lower geometric mean m
4 r study, 34 blacks with stable CAD receiving acetylsalicylic acid 75 to 100 mg/d were randomized to c
5 ooxygenases in Drosophila and the failure of acetylsalicylic acid, a potent inhibitor of both COX-1 a
6                                              Acetylsalicylic acid, acetaminophen, atenolol, diclofena
7 ebruary 2007) and the search term aspirin or acetylsalicylic acid and dose.
8                                Indomethacin, acetylsalicylic acid and ibuprofen abolished the alterna
9 a minority of patients have a sensitivity to acetylsalicylic acid and other nonsteroidal anti-inflamm
10 ylated bovine serum albumin was inhibited by acetylsalicylic acid and sodium acetate as well as by N-
11       Hypersensitivity reactions to aspirin (acetylsalicylic acid) and other nonsteroidal anti-inflam
12 ly to groups given 0.5 mug calcitriol, 75 mg acetylsalicylic acid, and 1250 mg calcium carbonate (n =
13 idine, loratadine, ibuprofen, acetaminophen, acetylsalicylic acid, and cocaine in various forms.
14                The Antiphospholipid Antibody Acetylsalicylic Acid (APLASA) study was a multicenter, r
15                        Sodium salicylate and acetylsalicylic acid are drugs used as anti-inflammatory
16             In blood from subjects receiving acetylsalicylic acid (ASA or aspirin), none of the measu
17 this study, we observed that pretreatment by acetylsalicylic acid (ASA) augmented TRAIL-induced apopt
18                          Hypersensitivity to acetylsalicylic acid (ASA) constitutes a serious problem
19 by positive drug provocation test (DPT) with acetylsalicylic acid (ASA) during 2005-2012 (V1) were in
20 e (PUD) in a cohort of new users of low-dose acetylsalicylic acid (ASA) for secondary prevention of c
21           The current study explored whether acetylsalicylic acid (ASA) had cytokine-repressing activ
22 agonist (VKA) monotherapy, 25,458 (35%) with acetylsalicylic acid (ASA) monotherapy and 8,962 (13%) w
23  glioma, treatment with the COX-2 inhibitors acetylsalicylic acid (ASA) or celecoxib inhibited system
24                  In this study, we show that acetylsalicylic acid (ASA) treatment is able to signific
25        The effects of salicylic acid (SA) or acetylsalicylic acid (ASA) treatments during on-tree che
26                 The next day, sensitivity to acetylsalicylic acid (ASA) was proven in all patients wi
27                         Morphine, MK-801 and acetylsalicylic acid (ASA) were active systemically in t
28 2-0.79) among patients who received low-dose acetylsalicylic acid (ASA), 0.18 (95% CI, 0.04-0.79) for
29 euticals and personal care products (PPCPs) [acetylsalicylic acid (ASA), 2,5-dihydroxybenzoic acid (D
30           In this study, we examined whether acetylsalicylic acid (ASA), so-called aspirin, enhances
31 olymorphism (PlA2) on platelet inhibition by acetylsalicylic acid (ASA, i.e., aspirin), clopidogrel,
32     Previous studies indicated that aspirin (acetylsalicylic acid [ASA]) can have profound immunomodu
33                    The inability of aspirin (acetylsalicylic acid [ASA]) to adequately suppress plate
34 n diabetic patients taking low-dose aspirin (acetylsalicylic acid, ASA), suggesting that such patient
35 igate the effect of three different doses of acetylsalicylic acid (aspirin) (ASA) on the late phase o
36                                              Acetylsalicylic acid (aspirin) and the naturally occurri
37 intensity ultrasound were investigated using acetylsalicylic acid (aspirin) crystals as a model compo
38  intestinal epithelia and when acetylated by acetylsalicylic acid (aspirin) initiates the biosynthesi
39                                              Acetylsalicylic acid (aspirin) is a cyclooxygenase (COX)
40                                     Although acetylsalicylic acid (aspirin) is commonly used for pati
41                                              Acetylsalicylic acid (aspirin) is highly effective for t
42                                              Acetylsalicylic acid (aspirin) is one of the most widely
43                                              Acetylsalicylic acid (aspirin) is the drug most commonly
44                                     Low-dose acetylsalicylic acid (aspirin) is widely used in the tre
45 gage items like detergent, sweetener, sugar, acetylsalicylic acid (aspirin), and paracetamol-caffeine
46  trial to determine whether a combination of acetylsalicylic acid (aspirin), calcitriol, and calcium
47 een with nonselective COX inhibitors such as acetylsalicylic acid (aspirin).
48 ic human HNPCC tumor cell lines treated with acetylsalicylic acid (aspirin; ASA) and three isomeric d
49              The potential energy surface of acetylsalicylic acid, aspirin, has been explored at the
50                                     Low-dose acetylsalicylic acid at the time of bloodstream infectio
51 urred to varying degrees upon treatment with acetylsalicylic acid, benzoic acid, 2,4-dichlorophenoxya
52  azithromycin was significantly inhibited by acetylsalicylic acid but not by the other antipyretics.
53 uggest a direct antistaphylococcal effect of acetylsalicylic acid, but evidence from human studies is
54 umented as on antiplatelet therapy if taking acetylsalicylic acid, clopidogrel, and/or ticlopidine.
55                 Furthermore, experience with acetylsalicylic acid desensitization in patients with CA
56 nted to determine the safety and efficacy of acetylsalicylic acid desensitization therapy in patients
57 national normalized ratio levels or those on acetylsalicylic acid had a decrease in risk of thrombosi
58 mation only after concomitant treatment with acetylsalicylic acid, indicating that defective glycopro
59 re required to investigate if early low-dose acetylsalicylic acid is a suitable treatment in patients
60                      Regular use of aspirin (acetylsalicylic acid) is associated with reduced inciden
61                                     Aspirin (acetylsalicylic acid) is widely used for the acute treat
62                                     Low-dose acetylsalicylic acid (LDA) administered before 16 weeks'
63 idogrel is uniform for all patients or, like acetylsalicylic acid, more selective.
64 renal oximetry), prevention (statin therapy, acetylsalicylic acid, N-acetylcysteine, sodium bicarbona
65 e influence of ibuprofen, acetaminophen, and acetylsalicylic acid on uptake, transport, and release o
66 s study, we analyzed the effects of aspirin (acetylsalicylic acid) on serine phosphorylation of insul
67 s reperfusion therapy, and were treated with acetylsalicylic acid, P2Y12 inhibitors, and statins to a
68                         Reperfusion therapy, acetylsalicylic acid, P2Y12 inhibitors, and statins were
69                                     Aspirin (acetylsalicylic acid) prophylaxis suppresses major adver
70              Repeated oral administration of acetylsalicylic acid reduced all emissions.
71  clofibrate, di(2-ethylhexyl) phtalhate, and acetylsalicylic acid resulted in differential increases
72  increased risk was identified compared with acetylsalicylic acid (RR, 14.96; 95% CI, 0.85-262.00; 1
73                           Most patients with acetylsalicylic acid sensitivity are able to undergo des
74                                              Acetylsalicylic acid sensitivity is common and desensiti
75                     Patients taking aspirin (acetylsalicylic acid) showed mean blood loss of 43.26 +/
76            After successful desensitization, acetylsalicylic acid therapy must be indefinitely contin
77  We aimed to estimate the effect of low-dose acetylsalicylic acid therapy on mortality in bloodstream
78 agents (e.g., statins), antiplatelet agents (acetylsalicylic acid, thienopyridines, thianopyridines,
79  patients with stable CAD receiving low-dose acetylsalicylic acid, ticagrelor provided a faster onset
80                    Using the Apixaban versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrill
81                                              Acetylsalicylic acid treatment did not attenuate the dev
82 hich was strongly associated with a low-dose acetylsalicylic acid use (p < 0.001).
83                                     Low-dose acetylsalicylic acid use was associated with a reduced 3
84                        In contrast, low-dose acetylsalicylic acid use was not associated with the pri
85      Age, sex, DBP, prior GI bleeding, prior acetylsalicylic acid use, and anemia were associated wit
86 tive pulmonary disease or GI bleeding, prior acetylsalicylic acid use, and anemia were independently
87 atients, respectively (1:1 match of low-dose acetylsalicylic acid users and nonusers).
88 l multicenter randomized controlled trial of acetylsalicylic acid versus warfarin for thromboprophyla
89 equivocal, and combinations of nitrates with acetylsalicylic acid were inactive.
90 ion, globe massage, and anticoagulation with acetylsalicylic acid were prescribed.
91 salicylate and salicylate precursors such as acetylsalicylic acid with certain other drugs.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。